ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 192,37
0,30%
Dow Jones
40 003,59
0,34%
DAX
18 762,76
0,30%
Brent Oil
83,77
0,21%
Bitcoin
66 796,84
0,96%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Omrix Biopharmaceuticals (MM) (OMRI)

  7. Omrix Biopharmaceuticals (MM) (OMRI) Actualités

OMRI

Omrix Biopharmaceuticals (MM) (OMRI)

Omrix Biopharmaceuticals (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:OMRI
DateHeureSourceTitreSymboleSociété
30/12/200823h21Edgar (US Regulatory)(25-NSE)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
30/12/200822h59Edgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities under Section 12(g) (15F-12G)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
30/12/200821h34Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
29/12/200815h57MarketwiredBridgewaterEquity.com Free Fundamental Sector & Market Research on BEBE, OMRI, SONS and CALMNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
29/12/200812h27Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
27/12/200816h08PR Newswire (US)Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200823h42PR Newswire (US)Johnson & Johnson Extends Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
19/12/200822h49Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
18/12/200822h02Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/12/200823h40PR Newswire (US)Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
03/12/200819h45MarketwiredLaw Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit on Behalf of Shareholders of Omrix Biopharmaceuticals, IncNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
26/11/200812h01Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200823h12Edgar (US Regulatory)Current report filing (8-K)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200819h10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200818h43Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
25/11/200818h38PR Newswire (US)Johnson & Johnson Begins Tender Offer to Acquire OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
24/11/200823h06Edgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
24/11/200812h30PR Newswire (US)Johnson & Johnson Announces Definitive Agreement to Acquire OmrixNASDAQ:OMRI
10/11/200817h25Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
06/11/200819h47Business WireOmrix Biopharmaceuticals to Webcast Presentation at Credit Suisse Annual Healthcare ConferenceNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
06/11/200818h16Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
06/11/200813h00Business WireOmrix Biopharmaceuticals Announces Third Quarter 2008 Financial ResultsNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
05/11/200822h52Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
04/11/200814h00Business WireOmrix Biopharmaceuticals to Webcast Presentation at Rodman & Renshaw Annual Healthcare ConferenceNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
03/11/200814h00Business WireOmrix Biopharmaceuticals Reschedules its Third Quarter 2008 Financial Results & Conference Call to an Earlier Time on Novembe...NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
24/10/200821h27Business WireOmrix Biopharmaceuticals Announces Patient Enrollment Will Resume In Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moder...NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
21/10/200814h00Business WireOmrix Biopharmaceuticals Announces Third Quarter 2008 Financial Results Date and Conference CallNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
20/10/200813h12Business WireOmrix Biopharmaceuticals Provides Preliminary Third Quarter 2008 Results and Increases 2008 Product Sales GuidanceNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
14/10/200813h00Business WireOmrix Biopharmaceuticals Receives Approval from European Medicines Agency for Evicel Liquid Fibrin Sealant (Human)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
10/10/200823h05Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:OMRI

Dernières Valeurs Consultées

EU
ORA
Orange
EU
AF
Air FranceKLM
NYSE
JPM
JP Morgan Chase
EU
RNO
Renault
NASDAQ
NVDA
NVIDIA
COIN
ETHUSD
Ethereum
SPI
SP500
S&P 500
EU
HO
Thales
EU
LR
Legrand
NASDAQ
MSFT
Microsoft
EU
CS
Axa
EU
VIV
Vivendi
EU
RI
Pernod Ricard
NYSE
MCD
McDonalds
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés